---
title: Tenifo
image: "/uploads/05-tenifo.jpg"
group: Hepatitis B
ingredient: Tenofovir Disoproxil Fumarat
excipients: Microcrystalline cellulose, dibasic calcium phosphate, lactose, povidone
  K30, purified talc, magnesium stearate, aerosil, sodium glycolate starch, corn starch,
  hypromellose, titanium dioxide, brilliant blue.
assign: "- Treatment of HIV infection: According to the guidelines of the Ministry
  of Health, TENIFO is indicated in combination with other antiretroviral drugs to
  treat HIV-1 infection in adults and children over 10 years old, pregnant and breastfeeding
  women. \n- Hepatitis B: TENIFO is indicated for the treatment of hepatitis B in
  adults with compensated liver function, with evidence of viral replication activity,
  persistently elevated alanine aminotrasferase (ALT) levels, and tissue evidence.
  of active inflammation and/or fibrosis."
expiry_date: 36 months
pack: ''
preservation: Store in a cool and dry place below 30Â°C, protected from light.
origin: India
amount_use: |-
  Adults and children over 35 kg: The recommended dose is 300 mg (1 tablet) once a day with meals.
  Children: Target dose for children over 10 years of age (<35 kg): 8 mg/kg or 200 mg/m2 (maximum 300 mg).
  Elderly: There are no data on dosing in elderly patients over 65 years of age.
  Patients with renal impairment: Dosage intervals should be adjusted for patients with creatinine clearance < 50 ml/min as directed by the physician.
contraindications: Patients who are sensitive to the components of the drug.
careful: |-
  It must not be used together with any other medicine containing tenofovir disoproxil fumarate.
  CKD.
  Liver failure.
  Lactic acidosis.
  Immune response syndrome.

---
